Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Components of Share-Based Compensation Expense

The following table sets forth the share-based compensation for the periods presented:

	Year Ended December 31,
	2025		2024		2023
Cost of goods sold	$	1,432	$	985	$	363
Research and development		39,600		43,449		25,750
Selling, general, and administrative		23,621		22,375		17,597
Restructuring costs		455		431		—
Total	$	65,108	$	67,240	$	43,710

Schedule of Profit Interest Activity

The following table sets forth the changes in the Company’s outstanding 2021 Omnibus Equity Incentive Plan non-option awards for the years ended December 31, 2025 and 2024:

	Number of Shares			Weighted average grant date fair value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Nonvested shares as of December 31, 2023		13,652,946		$	6.80
Granted		10,449,306		$	6.08
Vested		(7,565,367	)	$	6.76	—
Forfeited		(1,710,039	)	$	7.23
Nonvested shares as of December 31, 2024		14,826,846		$	7.09
Granted		15,265,807		$	3.63
Vested		(11,213,339	)	$	5.28	—
Forfeited		(3,133,046	)	$	7.09
Nonvested shares as of December 31, 2025		15,746,268		$	5.01

The following table sets forth the changes in the Company’s outstanding 2023 Inducement Plan non-option awards for the year ended December 31, 2025 and 2024:

	Number of Shares			Weighted average grant date fair value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Nonvested shares as of December 31, 2023		1,614,463		$	8.97
Granted		1,071,639		$	6.16
Vested		(548,986	)	$	8.75	—
Forfeited		(269,800	)	$	9.23
Nonvested shares as of December 31, 2024		1,867,316		$	7.48
Granted		1,351,300		$	4.01
Vested		(728,579	)	$	7.53	—
Forfeited		(306,723	)	$	6.35
Nonvested shares as of December 31, 2025		2,183,314		$	5.48

Schedule of Changes in Outstanding Options

The following table sets forth the changes in the Company’s outstanding options in the 2021 Plan for the years ended December 31, 2025 and 2024:

	Options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Outstanding at December 31, 2023		318,208		$	10.58		8.08	$	—
Granted	—			$	—
Exercised	—			$	—
Forfeited or expired		(17,743	)	$	6.60
Outstanding at December 31, 2024		300,465		$	10.82		7.06	$	—
Granted	—			$	—
Exercised	—			$	—
Forfeited or expired		(54,640	)	$	8.75
Outstanding at December 31, 2025		245,825		$	11.28		6.03	$	—
Exercisable at December 31, 2025		184,364		$	11.28		6.03	$	—
Vested or expected to vest		184,364		$	11.28		6.03	$	—

The following table sets forth the changes in the Company’s outstanding options for the years ended December 31, 2025 and 2024:

	Options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Outstanding at December 31, 2023		924,680		$	0.17		3.82	$	7,343
Exercised		(297,017	)	$	0.18
Forfeited or expired		—		$	—
Outstanding at December 31, 2024		627,663		$	0.16		2.81	$	2,470
Exercised		(117,885	)	$	0.05
Forfeited or expired		(6,388	)	$	3.59
Outstanding at December 31, 2025		503,390		$	0.16		1.80	$	1,718
Exercisable at December 31, 2025		503,390		$	0.16		1.80	$	1,718
Vested or expected to vest		503,390		$	0.16		1.80	$	1,718